A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance

Sha Zhu, Vinit Shanbhag, Yanfang Wang, Jaekwon Lee, Michael Petris

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress. In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent. However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo. In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEFRAS7A-). Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEFRAS7A- cells relative to wild type parental cells. This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia. Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors. These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.

Original languageEnglish (US)
Pages (from-to)1952-1958
Number of pages7
JournalJournal of Cancer
Volume8
Issue number11
DOIs
StatePublished - 2017

Fingerprint

Cisplatin
Copper
Carcinogenesis
Neoplasms
Drug Therapy
Growth
Tumor Cell Line
Adenosine Triphosphatases
Reactive Oxygen Species
Fibroblasts
Transplants
Proteins
Therapeutics

Keywords

  • ATP7A
  • Cisplatin resistance
  • Copper transporter
  • Tumorigenesis

ASJC Scopus subject areas

  • Oncology

Cite this

A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance. / Zhu, Sha; Shanbhag, Vinit; Wang, Yanfang; Lee, Jaekwon; Petris, Michael.

In: Journal of Cancer, Vol. 8, No. 11, 2017, p. 1952-1958.

Research output: Contribution to journalArticle

Zhu, Sha ; Shanbhag, Vinit ; Wang, Yanfang ; Lee, Jaekwon ; Petris, Michael. / A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance. In: Journal of Cancer. 2017 ; Vol. 8, No. 11. pp. 1952-1958.
@article{f61dc97f23da400d8fc8fede0e5dc964,
title = "A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance",
abstract = "The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress. In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent. However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo. In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEFRAS7A-). Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEFRAS7A- cells relative to wild type parental cells. This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia. Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors. These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.",
keywords = "ATP7A, Cisplatin resistance, Copper transporter, Tumorigenesis",
author = "Sha Zhu and Vinit Shanbhag and Yanfang Wang and Jaekwon Lee and Michael Petris",
year = "2017",
doi = "10.7150/jca.19029",
language = "English (US)",
volume = "8",
pages = "1952--1958",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "11",

}

TY - JOUR

T1 - A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance

AU - Zhu, Sha

AU - Shanbhag, Vinit

AU - Wang, Yanfang

AU - Lee, Jaekwon

AU - Petris, Michael

PY - 2017

Y1 - 2017

N2 - The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress. In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent. However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo. In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEFRAS7A-). Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEFRAS7A- cells relative to wild type parental cells. This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia. Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors. These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.

AB - The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress. In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent. However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo. In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEFRAS7A-). Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEFRAS7A- cells relative to wild type parental cells. This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia. Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors. These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.

KW - ATP7A

KW - Cisplatin resistance

KW - Copper transporter

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=85025464760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025464760&partnerID=8YFLogxK

U2 - 10.7150/jca.19029

DO - 10.7150/jca.19029

M3 - Article

VL - 8

SP - 1952

EP - 1958

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 11

ER -